One hundred and forty-three HIV-infected pregnant women treated with highly active antiretroviral therapy for prevention of mother-to-child transmission during a five-year period and their offspring were studied retrospectively. Two mothers died during the period of study and no infant was infected. The study revealed a good outcome and compliance for follow-up.

This is a descriptive study of children surviving to eight years-of-age from a cohort of 44 HIV-infected children not on treatment. Seventeen (38.6%) survived to the age of eight years and are categorized as long-term survivors. Of the 16 children alive, 37.5% had mild symptoms with no immunodeficiency and are categorized as long-term non-progressors.